Pathogenesis and genetic basis for retinopathy of prematurity

Area of Science:

• Ophthalmology
• Neonatology
• Genetics

Background:

• Retinopathy of prematurity (ROP) is a significant cause of visual impairment in preterm infants.
• While risk factors like low birth weight and gestational age are known, individual variability in ROP progression remains unexplained.
• Genetic predisposition is increasingly suspected as a key factor influencing ROP development and severity.

Purpose of the Study:

• To explore the role of genetic differences in the pathogenesis of retinopathy of prematurity.
• To investigate whether genetic polymorphisms influence the variable outcomes of ROP in preterm infants.
• To assess the potential of genetic screening for identifying infants at high risk for severe ROP.

Main Methods:

• Review of existing literature on ROP risk factors and genetic associations.
• Analysis of indirect evidence suggesting a genetic component in ROP.
• Discussion of candidate genes, such as VEGF, involved in retinal vascularization.

Main Results:

• ROP incidence varies by ethnicity and sex, suggesting underlying genetic influences.
• Genetic polymorphisms may affect genes controlling retinal vascularization, impacting ROP progression.
• Existing interventions do not always prevent ROP progression, highlighting the need for alternative explanations like genetics.

Conclusions:

• Genetic factors likely play a crucial role in the variable progression of retinopathy of prematurity.
• Evaluating genetic polymorphisms may offer new insights into ROP pathogenesis.
• Genetic screening could enable timely identification and treatment of high-risk preterm infants.